S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MNPR Monopar Therapeutics Inc

48.84

0.84 (1.75%)

Feb 05 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Monopar Therapeutics (NASDAQ:MNPR)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Monopar Therapeutics Charts.

Monopar Therapeutics (NASDAQ:MNPR)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Monopar Therapeutics Charts.

Monopar Therapeutics Inc News

Form EFFECT - Notice of Effectiveness
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics
Thursday 23 January 2025 (2 weeks ago) • PR Newswire (US)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 15 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 23 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 23 December 2024 (1 month ago) • Edgar (US Regulatory)

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
Friday 20 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 18 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

More Monopar Therapeutics Inc News Articles

Adia Nutrition (PK)

Decentral Life (PK)

MineralRite (PK)

TransCode Therapeutics

RespireRx Pharmaceuticals (CE)

Virexit Technologies (PK)

Liquidmetal Technologies (QB)

Elite Pharmaceuticals (QB)

Enanta Pharmaceuticals

Rennova Health (CE)

Super Micro Computer

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions